Production cross-section calculations of medical P-32, Sn-117, Sm-153 and Re-186,Re-188 radionuclides used in bone pain palliation treatment


Demir B., KAPLAN A. , ÇAPALI V. , Sarpun I. .. H. , Aydin A., Tel E.

KERNTECHNIK, vol.80, no.1, pp.58-65, 2015 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 80 Issue: 1
  • Publication Date: 2015
  • Doi Number: 10.3139/124.110477
  • Title of Journal : KERNTECHNIK
  • Page Numbers: pp.58-65

Abstract

In this study, production cross-section calculations of P-32, Sn-117, Sm-153 and Re-186,Re-188 radionuclides used in bone pain palliation treatment produced by Si-30(d,gamma)P-32, Sn-118(gamma,n)Sn-117, Sn-116(n,gamma)Sn-117, Nd-150(alpha,n)Sm-153, Sm-154(n,2n)Sm-153, Sm-152 (n,gamma)Sm-153, W-186(d,2n)Re-186, Re-187(gamma,n)Re-186, Re-185(n,gamma)Re-186 and Re-187(n,gamma)Re-188 reactions have been investigated in the different incident energy range of 0.003-34 MeV. Two-component exciton and generalised superfluid models of the TALYS 1.6 and exciton and generalised superfluid models of the EMPIRE 3.1 computer codes have been used to pre-equilibrium (PEQ) reaction calculations. The calculated production cross-section results have been compared with available experimental results existing in the experimental nuclear reaction database (EXFOR). Except the Sn-118(gamma,n)Sn-117, Nd-150 (alpha,n)Sm-153 and Re-185(n,gamma)Re-186 reactions, the two-component exciton model calculations of TALYS 1.6 code exhibit generally good agreement with the experimental measurements for all reactions used in this present study.